UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Determinants of Hepatitis C Virus Treatment Completion and Efficacy in Drug Users Assessed by Meta-analysis

Clinical infectious diseases, 2013-03, Vol.56 (6), p.806-816

2013

Volltextzugriff (PDF)

The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection

Journal of viral hepatitis, 2007-10, Vol.14 (10), p.675-687

2007

Volltextzugriff (PDF)

The new paradigm of hepatitis C therapy: integration of oral therapies into best practices

Journal of viral hepatitis, 2013-11, Vol.20 (11), p.745-760

2013

Volltextzugriff (PDF)

Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance

Journal of viral hepatitis, 2012-01, Vol.19 (1), p.47-54

2012

Volltextzugriff (PDF)

Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C

Blood, 2005-08, Vol.106 (4), p.1175-1182

2005

Volltextzugriff (PDF)

Normal Functional Capacity in Circulating Myeloid and Plasmacytoid Dendritic Cells in Patients with Chronic Hepatitis C

The Journal of infectious diseases, 2005-08, Vol.192 (3), p.497-503

2005

Volltextzugriff (PDF)

Response to Commentary on Zeremski et al. (2016): Improvements in HCV-related Knowledge Among Substance Users on Opioid Agonist Therapy After an Educational Intervention

Journal of addiction medicine, 2016-09, Vol.10 (5), p.364-365

2016

Volltextzugriff (PDF)

Presence of functional dendritic cells in patients chronically infected with hepatitis C virus

Blood, 2004-02, Vol.103 (3), p.1026-1029

2004

Volltextzugriff (PDF)

Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy

Journal of acquired immune deficiency syndromes (1999), 2009-12, Vol.52 (5), p.595-599

2009

Volltextzugriff (PDF)

Improvements in HCV-related Knowledge Among Substance Users on Opioid Agonist Therapy After an Educational Intervention

Journal of addiction medicine, 2016-03, Vol.10 (2), p.104-109

2016

Volltextzugriff (PDF)

Pharmacodynamics of PEG-IFN α differentiate HIV/HCV coinfected sustained virological responders from nonresponders

Hepatology (Baltimore, Md.), 2006-05, Vol.43 (5), p.943-953

2006

Volltextzugriff (PDF)

Histological Findings and Clinical Characteristics Associated with Hepatic Steatosis in Patients Coinfected with HIV and Hepatitis C Virus

The Journal of infectious diseases, 2005-12, Vol.192 (11), p.1943-1949

2005

Volltextzugriff (PDF)

Hepatitis C virus-specific immune responses in noninjecting drug users

Journal of viral hepatitis, 2012-08, Vol.19 (8), p.554-559

2012

Volltextzugriff (PDF)

Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users

Journal of viral hepatitis, 2009-01, Vol.16 (1), p.10-20

2009

Volltextzugriff (PDF)

Noninvasive markers of hepatic fibrosis: Are they ready for prime time in the management of HIV/HCV co-infected patients?

Journal of hepatology, 2005-07, Vol.43 (1), p.2-5

2005

Volltextzugriff (PDF)

Autoimmune hepatitis in the HIV-infected patient: a therapeutic dilemma

AIDS patient care and STDs, 2009-06, Vol.23 (6), p.407-413

2009

Volltextzugriff (PDF)

A hepatitis C viral kinetic model that allows for time-varying drug effectiveness

Antiviral therapy, 2008-01, Vol.13 (7), p.919-926

2008

Volltextzugriff (PDF)

A preliminary study of erythropoietin for anemia associated with ribavirin and interferon-α

The American journal of gastroenterology, 2001-09, Vol.96 (9), p.2802-2804

2001

Volltextzugriff (PDF)

Clinical and Biologic Importance of F-Actin Autoantibodies in HCV Monoinfected and HCV-HIV Coinfected Patients

American journal of clinical pathology, 2010-08, Vol.134 (2), p.228-234

2010

Volltextzugriff (PDF)

Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients

The Journal of immunology (1950), 2003-03, Vol.170 (6), p.3429-3439

2003

Volltextzugriff (PDF)

Hepatitis C Virus in Human Immunodeficiency Virus-Infected Individuals: An Emerging Comorbidity with Significant Implications

Seminars in liver disease, 2003-05, Vol.23 (2), p.149-166

2003

Volltextzugriff (PDF)

CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection

Clinical and experimental immunology, 2004-08, Vol.137 (2), p.408-416

2004

Volltextzugriff (PDF)

Changing treatment paradigms: hepatitis C virus in HIV-infected patients

AIDS patient care and STDs, 2007-03, Vol.21 (3), p.154-168

2007

Volltextzugriff (PDF)

Modeling Viral and Drug Kinetics: Hepatitis C Virus Treatment with Pegylated Interferon Alfa-2b

Seminars in liver disease, 2003-01, Vol.23 (S 1), p.013-018

2003

Volltextzugriff (PDF)

Hepatic inflammatory cytokine mRNA expression in hepatitis C virus-human immunodeficiency virus co-infection

Journal of viral hepatitis, 2008-05, Vol.15 (5), p.331-338

2008

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(53)

Sprache

Englisch
(53)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Determinants of Hepatitis C Virus Treatment Completion and Efficacy in Drug Users Assessed by Meta-analysis

The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection

The new paradigm of hepatitis C therapy: integration of oral therapies into best practices

Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance

Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C

Normal Functional Capacity in Circulating Myeloid and Plasmacytoid Dendritic Cells in Patients with Chronic Hepatitis C

Response to Commentary on Zeremski et al. (2016): Improvements in HCV-related Knowledge Among Substance Users on Opioid Agonist Therapy After an Educational Intervention

Presence of functional dendritic cells in patients chronically infected with hepatitis C virus

Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy

Improvements in HCV-related Knowledge Among Substance Users on Opioid Agonist Therapy After an Educational Intervention

Pharmacodynamics of PEG-IFN α differentiate HIV/HCV coinfected sustained virological responders from nonresponders

Histological Findings and Clinical Characteristics Associated with Hepatic Steatosis in Patients Coinfected with HIV and Hepatitis C Virus

Hepatitis C virus-specific immune responses in noninjecting drug users

Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users

Noninvasive markers of hepatic fibrosis: Are they ready for prime time in the management of HIV/HCV co-infected patients?

Autoimmune hepatitis in the HIV-infected patient: a therapeutic dilemma

A hepatitis C viral kinetic model that allows for time-varying drug effectiveness

A preliminary study of erythropoietin for anemia associated with ribavirin and interferon-α

Clinical and Biologic Importance of F-Actin Autoantibodies in HCV Monoinfected and HCV-HIV Coinfected Patients

Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients

Hepatitis C Virus in Human Immunodeficiency Virus-Infected Individuals: An Emerging Comorbidity with Significant Implications

CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection

Changing treatment paradigms: hepatitis C virus in HIV-infected patients

Modeling Viral and Drug Kinetics: Hepatitis C Virus Treatment with Pegylated Interferon Alfa-2b

Hepatic inflammatory cytokine mRNA expression in hepatitis C virus-human immunodeficiency virus co-infection

Suchergebnisse filtern